Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

A recombinant IL-4-Pseudomonas exotoxin inhibits protein synthesis and overcomes apoptosis resistance in human CLL B cells.

Kay NE, Bone ND, Lee YK, Jelinek DF, Leland P, Battle TE, Frank DA, Puri RK.

Leuk Res. 2005 Sep;29(9):1009-18. Epub 2005 Apr 12.

PMID:
16038727
3.

Interleukin-13 inhibits interleukin-2-induced proliferation and protects chronic lymphocytic leukemia B cells from in vitro apoptosis.

Chaouchi N, Wallon C, Goujard C, Tertian G, Rudent A, Caput D, Ferrera P, Minty A, Vazquez A, Delfraissy JF.

Blood. 1996 Feb 1;87(3):1022-9.

4.

Interleukin-4 inhibits apoptotic cell death and loss of the bcl-2 protein in B-chronic lymphocytic leukaemia cells in vitro.

Panayiotidis P, Ganeshaguru K, Jabbar SA, Hoffbrand AV.

Br J Haematol. 1993 Nov;85(3):439-45.

PMID:
8136263
5.
6.
7.

Interleukin 4 receptor on human lung cancer: a molecular target for cytotoxin therapy.

Kawakami M, Kawakami K, Stepensky VA, Maki RA, Robin H, Muller W, Husain SR, Puri RK.

Clin Cancer Res. 2002 Nov;8(11):3503-11.

8.

Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression.

Dancescu M, Rubio-Trujillo M, Biron G, Bron D, Delespesse G, Sarfati M.

J Exp Med. 1992 Nov 1;176(5):1319-26.

10.

Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells.

Secchiero P, Corallini F, Barbarotto E, Melloni E, di Iasio MG, Tiribelli M, Zauli G.

J Cell Physiol. 2006 Apr;207(1):158-64.

PMID:
16270354
12.
14.
15.

Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells.

Fluckiger AC, Durand I, Banchereau J.

J Exp Med. 1994 Jan 1;179(1):91-9.

16.

Thioredoxin prolongs survival of B-type chronic lymphocytic leukemia cells.

Nilsson J, Söderberg O, Nilsson K, Rosén A.

Blood. 2000 Feb 15;95(4):1420-6.

17.
18.

IL-24 induces apoptosis of chronic lymphocytic leukemia B cells engaged into the cell cycle through dephosphorylation of STAT3 and stabilization of p53 expression.

Sainz-Perez A, Gary-Gouy H, Gaudin F, Maarof G, Marfaing-Koka A, de Revel T, Dalloul A.

J Immunol. 2008 Nov 1;181(9):6051-60.

19.

Modulation of the human equilibrative nucleoside transporter1 (hENT1) activity by IL-4 and PMA in B cells from chronic lymphocytic leukemia.

Fernández Calotti P, Galmarini CM, Cañones C, Gamberale R, Saénz D, Avalos JS, Chianelli M, Rosenstein R, Giordano M.

Biochem Pharmacol. 2008 Feb 15;75(4):857-65. Epub 2007 Oct 22.

PMID:
18078872
20.

Supplemental Content

Support Center